Electric Mobility: Where are we Headed?

Anumita Roychowdhury is Executive Director- Research and Advocacy, at Centre for Science and Environment (CSE). She also heads some of the Centre’s key programmes on Clean Air, Sustainable Mobility and Sustainable Urbanisation.

Anumita has had a distinguished career in research, communication and advocacy. She has spearheaded CSE’s campaign on Right to Clean Air that has catalysed several developments beginning with the replacement of diesel-based public transport vehicles with a natural gas-based fleet in Delhi; improvement in emissions standards for vehicles; curtailment of the use of dirty fuels in industry in Delhi; and promotion of policies on sustainable mobility. She is also steering CSE’s global programme on clean air in Africa.

Anumita has written and published widely on environmental issues. Her notable works include Slow Murder: The Deadly Story of Vehicular Pollution in India, Good News & Bad News: Clearing the Air in Indian Cities, The Leapfrog Factor and a range of reports on zero emissions roadmap for vehicles and thermal comforts in buildings. She has been actively involved in several national policy forums as well global environmental platforms. She has also played a strong international role in contributing towards urban air quality management strategies and participated as a member and an advisor in national and international committees and organisations. She is a recipient of the prestigious 2016 Haagen Smit Clean Air Award given by the California Air Resources Board/California Environmental Protection Agency of the State of California, USA.

Dr Sachin S. Bhagwat has 28 years of experience in the discovery and development of novel antibiotics. He began his discovery research career at Ranbaxy Laboratories, New Delhi (1995-1998) and later on joined antibiotic discovery team at Wockhardt Research Center, Aurangabad (1998-till date) eventually leading the preclinical evaluation of NCEs. Focused and sustained efforts of >25 years at Wockhardt have led to a strong novel antibiotic pipeline with four NCEs at advanced clinical stage and two launched. Dr Bhagwat’s research interest includes, historical discovery approaches, unmet need in bacterial infections, mechanism of action and resistance, clinical dose identifying PK/PD studies, and international collaborative research. Dr Bhagwat is the inventor / co-inventor in 40+ granted US/EU patents covering five major antibacterial classes, fluoroquinolones, oxazolidinones, macrolide/ketolides, β-lactams and diazabicycloctane and has authored several original research articles. He earned his Ph.D. degree in 2002 (Bhopal University) on pharmacodynamic efficacy determinants of quinolone antibacterials.